Vitiligo

As 2023 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in vitiligo this year.

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

Investigators evaluated vitiligo punch grafting effectiveness on stable vitiligo lesions.

Sarkar spoke with Dermatology Times after the ReV conference to discuss her session on vitiligo stigma.

Delve into challenging vitiligo cases and solutions discussed at recent Dermatology Times Case Based Roundtable events across the country.

An expert in dermatology reviews the case of a 10-year-old male with segmental vitiligo, shedding light on the panel's gaps in understanding this complex condition. The conversation explores the treatment challenges and the emotional impact on patients, particularly those of Asian or Indian descent.

Karan Lal DO, MS, FAAD presents the case of a 51-year-old African American male with vitiligo, exploring insurance challenges, treatment options such as topical ruxolitinib, Excimer, and phototherapy, and strategies for setting and managing patient treatment response expectations.

Nanette Silverberg, MD, takes a deep dive into the importance of early intervention and gave an overview of topical care for patients of all ages with vitiligo.

An expert in dermatology presents the case of a 23-year-old male patient presenting with unstable vitiligo. He delves into treatment options available for managing this condition, shedding light on the nuances and optimal scenarios for each therapeutic agent.

James Song, MD, FAAD, presents the case of a 14-year-old male patient seeking vitiligo treatment. He emphasizes the significance of addressing mental health concerns alongside managing the physical symptoms of this condition. He further discusses possible approaches to treat the patient's depigmented patches, particularly considering that this patient was diagnosed with segmental vitiligo.

A recent study presents a unique case of sudden-onset vitiligo following the COVID-19 vaccination, along with a systematic review of existing literature to shed light on the potential link between vaccination and vitiligo development.

Catch up on coverage from this week's virtual Revolutionizing Atopic Dermatitis and Revolutionizing Vitiligo conferences.

David Rosmarin, MD, presented new and upcoming pipeline updates for the treatment of vitiligo at the Revolutionizing Vitiligo Virtual Conference.

Lesional stability is a necessary requirement for determining the course of treatment for vitiligo.

A poster presented at the 2023 ReV Virtual Conference explored the association between the 2 conditions.

Raj Chovatiya, MD, PhD, reviews a case of an adolescent patient with rapid changes in existing vitiligo.

The promising data on upadacitinib was presented at the 2023 Revolutionizing Vitiligo Virtual Conference.

Jordan Bui and Bernard A. Cohen, MD, review a case of a young patient with vitiligo.

Benjamin Lockshin, MD, FAAD, summarizes the panel's best practices for improving patient education on the risks and benefits of vitiligo treatment. He underscores the importance of establishing and managing expectations for treatment response.

An expert in dermatology discusses the case of an active 71-year-old female who spends considerable time outdoors. The expert summarizes the panel's recommendations for counseling the patient on the benefits of treatment compliance and the use of sun-sparing products to enhance her quality of life and treatment response.

Benjamin Lockshin, MD, FAAD, summarizes key points from a panel discussion on the utilization of topical treatments in vitiligo. The first case revolves a 31-year-old woman with distressing depigmentation and highlights the panel's treatment approach to the management of this condition in difficult to treat areas.

An expert in dermatology discusses the case of an active 62-year-old female, who is self-conscious about her condition, and explores how the panel would advise her to maintain her outdoor lifestyle while discussing effective topical treatments.

Heather C Woolery-Lloyd, MD, discusses a 23-year-old woman with vitiligo vulgaris affecting 75% of her face, including complete depigmentation. She explores the panel’s response to managing progressive disease and its impact on the patient's quality of life.

Recently, a significant breakthrough was achieved when 42 international vitiligo experts and 4 patient representatives collaborated and developed a consensus management strategy for vitiligo.

Experts Heather Woolery-Lloyd, MD; Chesahna Kindred, MD, MBA, FAAD; Gary M. Owens, MD; and Renata Block, MMS, PA-C, discuss the evolving landscape of vitiligo, particularly from an economic lens.